Free Trial

CTS (CTS) Financials

CTS logo
$37.49 +0.70 (+1.90%)
Closing price 03:59 PM Eastern
Extended Trading
$37.56 +0.07 (+0.20%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for CTS

Annual Income Statements for CTS

This table shows CTS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
27 6.95 34 14 47 36 35 -42 60 61 58
Consolidated Net Income / (Loss)
27 6.95 34 14 47 36 35 -42 60 61 58
Net Income / (Loss) Continuing Operations
27 6.95 34 14 47 36 35 -42 60 61 58
Total Pre-Tax Income
39 12 57 40 58 50 45 -61 81 75 71
Total Operating Income
42 18 63 38 61 54 45 76 93 75 73
Total Gross Profit
130 127 140 140 165 158 139 185 211 191 189
Total Revenue
404 382 397 423 470 469 424 513 587 550 516
Operating Revenue
404 382 397 423 470 469 424 513 587 550 516
Total Cost of Revenue
274 255 256 283 306 311 285 328 376 360 327
Operating Cost of Revenue
274 255 256 283 306 311 285 328 376 360 327
Total Operating Expenses
88 109 77 102 104 104 94 108 118 116 116
Selling, General & Admin Expense
61 60 62 72 74 70 68 83 92 84 88
Research & Development Expense
23 22 24 25 25 26 24 24 24 25 23
Restructuring Charge
5.94 15 3.05 4.14 5.06 7.45 1.83 1.69 1.91 7.07 4.70
Total Other Income / (Expense), net
-2.98 -5.85 -5.92 1.76 -2.94 -3.55 0.35 -137 -12 0.10 -1.56
Interest Expense
2.33 2.63 3.70 3.34 2.09 2.65 3.27 2.11 2.19 3.33 4.24
Interest & Investment Income
2.79 3.07 1.31 1.28 1.83 1.74 1.05 0.84 1.33 4.63 4.28
Other Income / (Expense), net
-3.44 -6.30 -3.52 3.82 -2.68 -2.64 2.58 -136 -11 -1.19 -1.60
Income Tax Expense
13 5.31 23 26 12 14 11 -19 21 15 13
Basic Earnings per Share
$0.79 $0.21 $1.05 $0.44 $1.41 $1.11 $1.07 ($1.30) $1.86 $1.93 $1.91
Weighted Average Basic Shares Outstanding
33.62M 32.96M 32.73M 32.89M 33.02M 32.70M 32.32M 32.33M 31.97M 31.36M 30.41M
Diluted Earnings per Share
$0.78 $0.21 $1.03 $0.43 $1.39 $1.09 $1.06 ($1.30) $1.85 $1.92 $1.89
Weighted Average Diluted Shares Outstanding
34.13M 33.48M 33.25M 33.42M 33.57M 33.11M 32.58M 32.33M 32.24M 31.58M 30.72M
Weighted Average Basic & Diluted Shares Outstanding
33.60M 33.10M 32.70M 32.80M 33M 64.87M 32.35M 32.15M 31.67M 30.79M 30.04M
Cash Dividends to Common per Share
$0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16

Quarterly Income Statements for CTS

This table shows CTS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
12 15 18 13 14 15 11 15 19 14
Consolidated Net Income / (Loss)
12 15 18 13 14 15 11 15 19 14
Net Income / (Loss) Continuing Operations
12 15 18 13 14 15 11 15 19 14
Total Pre-Tax Income
17 21 23 16 19 18 14 18 22 17
Total Operating Income
23 22 22 18 18 16 15 18 21 19
Total Gross Profit
53 51 52 51 46 42 45 46 50 48
Total Revenue
152 142 146 145 135 125 126 130 132 127
Operating Revenue
152 142 146 145 135 125 126 130 132 127
Total Cost of Revenue
99 91 94 94 88 83 81 84 83 80
Operating Cost of Revenue
99 91 94 94 88 83 81 84 83 80
Total Operating Expenses
31 29 29 32 28 26 31 29 28 29
Selling, General & Admin Expense
24 23 22 24 19 19 22 21 23 22
Research & Development Expense
6.21 5.41 6.59 6.72 6.32 5.29 6.60 6.09 5.03 5.67
Restructuring Charge
0.49 0.48 0.91 1.90 3.23 1.04 1.69 1.19 0.77 1.04
Total Other Income / (Expense), net
-5.35 -0.86 0.53 -2.35 0.55 1.37 -0.88 0.01 0.97 -1.66
Interest Expense
0.34 0.70 0.69 0.82 1.00 0.82 0.80 0.83 1.31 1.30
Interest & Investment Income
0.17 0.72 1.06 1.07 0.95 1.54 1.39 1.44 0.97 0.48
Other Income / (Expense), net
-5.17 -0.87 0.17 -2.61 0.59 0.66 -1.46 -0.60 1.31 -0.84
Income Tax Expense
5.50 5.83 4.37 3.18 4.77 2.31 2.54 3.06 3.76 3.74
Basic Earnings per Share
$0.37 $0.47 $0.58 $0.41 $0.45 $0.49 $0.36 $0.48 $0.62 $0.45
Weighted Average Basic Shares Outstanding
31.87M 31.97M 31.63M 31.49M 31.30M 31.36M 30.74M 30.51M 30.30M 30.41M
Diluted Earnings per Share
$0.37 $0.46 $0.58 $0.41 $0.44 $0.49 $0.36 $0.48 $0.61 $0.44
Weighted Average Diluted Shares Outstanding
32.09M 32.24M 31.89M 31.69M 31.51M 31.58M 30.99M 30.73M 30.54M 30.72M
Weighted Average Basic & Diluted Shares Outstanding
31.88M 31.67M 31.54M 31.36M 31.16M 30.79M 30.57M 30.37M 30.12M 30.04M
Cash Dividends to Common per Share
$0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04

Annual Cash Flow Statements for CTS

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
10 22 -43 -0.23 -13 -0.69 -8.47 50 15 6.97 -70
Net Cash From Operating Activities
33 39 47 58 58 64 77 86 121 89 99
Net Cash From Continuing Operating Activities
33 39 47 58 58 64 77 86 121 89 99
Net Income / (Loss) Continuing Operations
27 6.95 34 14 47 36 35 -42 60 61 58
Consolidated Net Income / (Loss)
27 6.95 34 14 47 36 35 -42 60 61 58
Depreciation Expense
17 16 19 21 23 25 27 27 30 29 31
Non-Cash Adjustments To Reconcile Net Income
6.69 24 -8.75 17 5.60 8.11 8.77 140 11 3.23 12
Changes in Operating Assets and Liabilities, net
-15 -5.47 4.18 6.37 -16 -4.47 6.65 -39 21 -3.66 -1.36
Net Cash From Investing Activities
-8.00 -9.13 -81 -37 -28 -96 -23 -16 -111 -18 -141
Net Cash From Continuing Investing Activities
-8.00 -9.13 -81 -37 -28 -96 -23 -16 -111 -18 -141
Purchase of Property, Plant & Equipment
-13 -9.72 -21 -18 -28 -22 -15 -16 -14 -15 -19
Acquisitions
0.00 -1.29 -73 -19 0.00 -74 -8.31 -0.26 -97 -3.36 -122
Net Cash From Financing Activities
-16 -7.83 -8.64 -21 -42 30 -61 -21 4.34 -65 -28
Net Cash From Continuing Financing Activities
-16 -7.83 -8.64 -21 -42 30 -61 -21 4.34 -65 -28
Repayment of Debt
-1,034 -1,344 -2,458 -1,519 -1,060 -1,886 -3,793 -809 -723 -775 -892
Repurchase of Common Equity
-8.00 -18 0.00 0.00 -9.44 -12 -8.08 -8.79 -21 -41 -43
Payment of Dividends
-5.37 -5.29 -5.23 -5.26 -5.29 -5.24 -5.18 -5.17 -5.13 -5.04 -4.89
Issuance of Debt
1,031 1,359 2,457 1,505 1,034 1,936 3,747 804 757 758 916
Other Financing Activities, net
0.58 -0.15 -1.81 -1.60 -1.47 -2.66 -2.97 -2.15 -2.72 -3.26 -4.21
Effect of Exchange Rate Changes
0.72 0.23 -0.42 -0.79 0.19 0.35 -0.75 0.16 1.10 1.65 -0.34
Cash Interest Paid
2.11 2.42 2.94 2.13 1.58 1.96 2.60 1.95 2.02 3.13 4.23
Cash Income Taxes Paid
7.99 6.78 10 11 9.92 11 12 17 20 20 17

Quarterly Cash Flow Statements for CTS

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
49 9.00 -13 7.34 9.23 3.76 -1.45 -1.18 -66 -0.54
Net Cash From Operating Activities
60 25 11 23 22 32 18 20 35 26
Net Cash From Continuing Operating Activities
60 25 11 23 22 32 18 20 35 26
Net Income / (Loss) Continuing Operations
12 15 18 13 14 15 11 15 19 14
Consolidated Net Income / (Loss)
12 15 18 13 14 15 11 15 19 14
Depreciation Expense
7.96 8.03 6.92 7.26 7.25 7.29 7.33 7.33 7.99 8.28
Non-Cash Adjustments To Reconcile Net Income
2.13 2.54 2.64 2.28 -3.37 1.68 2.14 0.29 4.74 4.45
Changes in Operating Assets and Liabilities, net
38 -0.04 -17 0.99 4.28 7.78 -2.27 -2.70 3.99 -0.38
Net Cash From Investing Activities
-2.27 -5.40 -7.90 -3.95 -2.75 -3.50 -4.04 -4.64 -126 -6.10
Net Cash From Continuing Investing Activities
-2.27 -5.40 -7.90 -3.95 -2.75 -3.50 -4.04 -4.64 -126 -6.10
Purchase of Property, Plant & Equipment
-2.27 -5.07 -4.54 -3.95 -2.75 -3.50 -4.04 -4.64 -3.87 -6.10
Net Cash From Financing Activities
-8.77 -11 -17 -13 -9.97 -25 -16 -16 25 -20
Net Cash From Continuing Financing Activities
-8.77 -11 -17 -13 -9.97 -25 -16 -16 25 -20
Repayment of Debt
-218 -205 -204 -46 -344 -181 -168 -168 -266 -291
Repurchase of Common Equity
-1.78 -8.00 -8.80 -8.76 -8.33 -15 -12 -11 -12 -7.81
Payment of Dividends
-1.28 -1.28 -1.27 -1.26 -1.26 -1.25 -1.23 -1.23 -1.22 -1.21
Issuance of Debt
212 203 201 42 343 172 168 165 303 280
Other Financing Activities, net
-0.16 -0.17 -3.14 -0.10 -0.01 -0.01 -3.12 -1.09 -0.02 0.02
Effect of Exchange Rate Changes
-0.18 0.23 -0.04 1.21 -0.18 0.66 0.58 -0.42 -0.55 0.05
Cash Interest Paid
0.55 0.50 0.93 0.79 0.63 0.78 0.74 0.82 1.22 1.45
Cash Income Taxes Paid
5.00 7.47 4.20 5.53 5.40 5.11 3.80 4.27 4.08 4.46

Annual Balance Sheets for CTS

This table presents CTS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
457 483 518 540 548 643 626 664 748 741 766
Total Current Assets
240 246 216 234 239 237 233 289 326 319 244
Cash & Equivalents
135 157 114 114 101 100 92 141 157 164 94
Accounts Receivable
57 55 63 71 80 78 81 82 91 79 78
Inventories, net
28 25 29 37 43 42 46 50 62 60 54
Other Current Assets
21 9.86 11 13 15 17 15 16 16 17 19
Plant, Property, & Equipment, net
71 70 82 88 99 105 97 97 97 93 94
Total Noncurrent Assets
145 168 220 218 210 301 295 278 325 329 427
Goodwill
32 34 62 71 71 106 109 110 152 158 200
Intangible Assets
37 35 64 67 60 85 79 70 108 104 164
Noncurrent Deferred & Refundable Income Taxes
43 64 46 21 22 20 24 25 23 25 28
Employee Benefit Assets
32 34 46 57 54 62 57 49 0.00 0.00 0.00
Other Noncurrent Operating Assets
1.25 1.34 1.74 2.10 2.04 28 26 24 42 42 36
Total Liabilities & Shareholders' Equity
457 483 518 540 548 643 626 664 748 741 766
Total Liabilities
167 202 200 196 170 238 202 201 242 214 235
Total Current Liabilities
80 95 98 102 104 97 105 114 113 97 98
Accounts Payable
43 40 40 49 52 48 50 56 53 43 43
Accrued Expenses
25 47 46 41 37 36 38 37 35 35 34
Current Employee Benefit Liabilities
11 7.15 11 12 15 9.56 13 18 20 15 16
Other Current Liabilities
- - - - 0.00 2.79 3.29 3.39 3.94 4.39 4.72
Total Noncurrent Liabilities
87 107 102 93 66 141 97 87 130 117 138
Long-Term Debt
75 91 89 76 50 100 55 50 84 68 91
Noncurrent Deferred & Payable Income Tax Liabilities
- - 2.37 3.80 3.99 5.64 7.01 5.89 16 15 13
Noncurrent Employee Benefit Liabilities
- - - - - 6.63 7.47 6.89 5.05 4.66 3.93
Other Noncurrent Operating Liabilities
9.11 9.17 3.21 6.18 5.92 29 28 24 25 30 30
Commitments & Contingencies
- - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
290 282 318 344 378 405 424 464 506 527 531
Total Preferred & Common Equity
290 282 318 344 378 405 424 464 506 527 531
Total Common Equity
290 282 318 344 378 405 424 464 506 527 531
Common Stock
339 342 343 346 350 352 353 357 363 364 367
Retained Earnings
380 382 411 420 479 510 539 492 547 602 655
Treasury Stock
-325 -343 -343 -343 -353 -364 -373 -381 -403 -444 -487
Accumulated Other Comprehensive Income / (Loss)
-104 -99 -93 -79 -98 -92 -96 -4.53 -0.67 4.26 -4.27

Quarterly Balance Sheets for CTS

This table presents CTS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
735 747 756 754 733 726 789
Total Current Assets
326 323 330 334 318 315 256
Cash & Equivalents
148 144 151 160 162 161 95
Accounts Receivable
97 98 98 90 81 85 86
Inventories, net
63 63 63 65 58 52 57
Other Current Assets
18 18 19 19 17 17 17
Plant, Property, & Equipment, net
96 96 95 93 92 92 93
Total Noncurrent Assets
312 328 331 327 323 319 440
Goodwill
139 156 156 154 156 156 195
Intangible Assets
106 110 109 104 100 97 181
Noncurrent Deferred & Refundable Income Taxes
23 23 23 24 26 27 27
Employee Benefit Assets
0.01 - 0.00 0.00 - 0.00 0.00
Other Noncurrent Operating Assets
44 39 44 45 41 39 38
Total Liabilities & Shareholders' Equity
735 747 756 754 733 726 789
Total Liabilities
244 233 235 231 212 203 259
Total Current Liabilities
122 106 107 103 96 92 104
Accounts Payable
66 53 53 50 46 41 45
Accrued Expenses
36 37 35 36 33 32 37
Current Employee Benefit Liabilities
17 12 14 13 13 15 17
Other Current Liabilities
3.53 4.03 4.29 4.44 4.40 4.37 4.59
Total Noncurrent Liabilities
122 127 127 128 116 110 155
Long-Term Debt
85 80 77 77 68 65 103
Noncurrent Deferred & Payable Income Tax Liabilities
5.52 16 16 15 14 14 14
Noncurrent Employee Benefit Liabilities
6.25 5.02 5.02 4.96 4.62 4.58 4.56
Other Noncurrent Operating Liabilities
25 26 29 31 29 27 34
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
491 514 521 523 521 523 531
Total Preferred & Common Equity
491 514 521 523 521 523 531
Total Common Equity
491 514 521 523 521 523 531
Common Stock
361 361 363 364 362 363 365
Retained Earnings
533 564 575 588 612 626 643
Treasury Stock
-395 -412 -420 -429 -456 -467 -479
Accumulated Other Comprehensive Income / (Loss)
-8.85 0.70 3.69 -0.68 2.94 0.78 2.02

Annual Metrics and Ratios for CTS

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.33% -5.37% 3.76% 6.63% 11.23% -0.32% -9.58% 20.95% 14.42% -6.21% -6.30%
EBITDA Growth
9.92% -52.18% 200.69% -18.24% 28.40% -6.28% -1.88% -143.94% 440.76% -7.89% -0.46%
EBIT Growth
100.19% -69.62% 404.76% -29.06% 37.93% -12.31% -6.79% -224.96% 236.90% -9.49% -3.63%
NOPAT Growth
1,358.87% -63.99% 269.28% -63.58% 253.79% -20.83% -11.06% 55.54% 28.19% -11.92% -1.76%
Net Income Growth
775.03% -73.78% 394.39% -57.98% 222.07% -22.32% -4.04% -220.70% 242.30% 1.61% -3.99%
EPS Growth
750.00% -73.08% 390.48% -58.25% 223.26% -21.58% -2.75% -222.64% 242.31% 3.78% -1.56%
Operating Cash Flow Growth
-11.24% 17.40% 20.56% 22.98% 0.18% 10.75% 19.22% 12.19% 40.70% -26.72% 11.80%
Free Cash Flow Firm Growth
-31.19% -44.90% -262.45% 103.59% 1,837.25% -237.17% 234.90% 29.18% -88.58% 712.00% -160.23%
Invested Capital Growth
-6.90% -6.45% 36.56% 4.20% 6.68% 23.76% -4.49% -3.72% 16.36% -0.59% 22.61%
Revenue Q/Q Growth
-0.49% -1.82% 2.14% 2.25% 1.99% -1.06% 1.92% 1.89% 1.69% -3.10% 0.53%
EBITDA Q/Q Growth
-10.59% -31.26% 18.35% -14.36% 25.71% -3.91% 9.89% -17.38% 6.66% -4.28% 2.25%
EBIT Q/Q Growth
5.78% -43.82% 27.40% -20.92% 37.73% -6.40% 15.55% -8.53% 7.40% -4.95% 1.79%
NOPAT Q/Q Growth
-22.95% -62.63% 176.40% -62.87% 199.51% -17.62% 11.42% 1.73% 6.12% -2.16% 1.34%
Net Income Q/Q Growth
29.24% -70.57% 176.88% -60.28% 203.20% -17.19% 16.40% -16.03% 10.73% 0.63% -2.87%
EPS Q/Q Growth
59.18% -16.00% 45.07% -67.42% 215.91% -17.42% 15.22% -16.07% 11.45% 1.59% -2.58%
Operating Cash Flow Q/Q Growth
21.63% -7.06% -3.86% -3.42% 8.41% 14.34% 5.23% -1.67% -0.46% 8.04% -5.80%
Free Cash Flow Firm Q/Q Growth
-41.22% -52.66% -5.31% -88.06% 328.84% -4.60% 7.19% 9.03% -49.41% 24.12% 7.04%
Invested Capital Q/Q Growth
-11.75% -8.47% 2.21% -1.99% 1.41% -0.50% -0.52% -1.78% 1.12% -2.00% -2.02%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
32.17% 33.25% 35.40% 33.20% 35.06% 33.60% 32.79% 35.99% 35.87% 34.68% 36.67%
EBITDA Margin
13.26% 6.70% 19.42% 14.89% 17.19% 16.16% 17.54% -6.37% 18.97% 18.63% 19.80%
Operating Margin
10.48% 4.74% 15.92% 9.10% 12.97% 11.47% 10.64% 14.91% 15.85% 13.64% 14.11%
EBIT Margin
9.63% 3.09% 15.04% 10.00% 12.40% 10.91% 11.25% -11.62% 13.90% 13.42% 13.80%
Profit (Net Income) Margin
6.56% 1.82% 8.67% 3.42% 9.89% 7.71% 8.18% -8.16% 10.15% 11.00% 11.27%
Tax Burden Percent
67.40% 56.72% 60.06% 35.89% 80.09% 71.91% 76.27% 68.77% 73.79% 80.55% 81.59%
Interest Burden Percent
101.18% 103.77% 95.98% 95.13% 99.56% 98.22% 95.34% 102.13% 98.94% 101.75% 100.06%
Effective Tax Rate
32.60% 43.28% 39.94% 64.11% 19.91% 28.09% 23.73% 0.00% 26.21% 19.46% 18.41%
Return on Invested Capital (ROIC)
11.95% 4.61% 14.89% 4.60% 15.43% 10.58% 8.70% 14.11% 17.05% 14.00% 12.39%
ROIC Less NNEP Spread (ROIC-NNEP)
15.63% 9.89% 22.80% 2.53% 20.76% 20.49% 7.29% 162.44% 28.04% 13.91% 14.95%
Return on Net Nonoperating Assets (RNNOA)
-2.90% -2.18% -3.42% -0.23% -2.54% -1.35% -0.33% -23.55% -4.76% -2.28% -1.41%
Return on Equity (ROE)
9.04% 2.43% 11.47% 4.37% 12.89% 9.23% 8.37% -9.44% 12.29% 11.72% 10.99%
Cash Return on Invested Capital (CROIC)
19.10% 11.28% -16.02% 0.49% 8.97% -10.66% 13.29% 17.91% 1.93% 14.59% -7.92%
Operating Return on Assets (OROA)
8.30% 2.51% 11.92% 8.00% 10.73% 8.59% 7.52% -9.24% 11.55% 9.92% 9.44%
Return on Assets (ROA)
5.66% 1.48% 6.87% 2.73% 8.55% 6.07% 5.46% -6.49% 8.43% 8.13% 7.71%
Return on Common Equity (ROCE)
9.04% 2.43% 11.47% 4.37% 12.89% 9.23% 8.37% -9.44% 12.29% 11.72% 10.99%
Return on Equity Simple (ROE_SIMPLE)
9.15% 2.47% 10.82% 4.20% 12.31% 8.92% 8.19% -9.03% 11.77% 11.49% 10.95%
Net Operating Profit after Tax (NOPAT)
29 10 38 14 49 39 34 54 69 60 59
NOPAT Margin
7.06% 2.69% 9.56% 3.27% 10.39% 8.25% 8.12% 10.44% 11.69% 10.98% 11.51%
Net Nonoperating Expense Percent (NNEP)
-3.68% -5.28% -7.91% 2.07% -5.33% -9.92% 1.42% -148.33% -10.99% 0.10% -2.55%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 11.63% 10.17% 9.55%
Cost of Revenue to Revenue
67.83% 66.75% 64.60% 66.80% 64.94% 66.40% 67.21% 64.01% 64.13% 65.33% 63.33%
SG&A Expenses to Revenue
15.11% 15.59% 15.54% 17.01% 15.64% 15.01% 15.99% 16.10% 15.59% 15.23% 17.12%
R&D to Revenue
5.58% 5.88% 6.06% 5.94% 5.38% 5.54% 5.73% 4.65% 4.11% 4.53% 4.53%
Operating Expenses to Revenue
21.69% 28.51% 19.48% 24.10% 22.09% 22.12% 22.15% 21.08% 20.03% 21.04% 22.56%
Earnings before Interest and Taxes (EBIT)
39 12 60 42 58 51 48 -60 82 74 71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
54 26 77 63 81 76 74 -33 111 103 102
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.95 1.95 2.22 2.39 2.21 2.36 2.58 2.53 2.47 2.58 2.99
Price to Tangible Book Value (P/TBV)
2.55 2.58 3.68 3.99 3.38 4.48 4.65 4.13 5.08 5.12 9.50
Price to Revenue (P/Rev)
1.40 1.44 1.78 1.94 1.77 2.04 2.58 2.28 2.13 2.47 3.08
Price to Earnings (P/E)
21.28 78.97 20.54 56.87 17.93 26.50 31.49 0.00 20.95 22.44 27.33
Dividend Yield
0.95% 0.95% 0.74% 0.64% 0.63% 0.54% 0.59% 0.44% 0.41% 0.37% 0.30%
Earnings Yield
4.70% 1.27% 4.87% 1.76% 5.58% 3.77% 3.18% 0.00% 4.77% 4.46% 3.66%
Enterprise Value to Invested Capital (EV/IC)
2.19 2.24 2.32 2.56 2.40 2.37 2.73 2.90 2.71 2.93 3.00
Enterprise Value to Revenue (EV/Rev)
1.25 1.26 1.72 1.85 1.67 2.04 2.49 2.11 2.00 2.29 3.07
Enterprise Value to EBITDA (EV/EBITDA)
9.42 18.85 8.86 12.45 9.69 12.63 14.18 0.00 10.55 12.30 15.52
Enterprise Value to EBIT (EV/EBIT)
12.98 40.87 11.44 18.54 13.42 18.71 22.11 0.00 14.40 17.09 22.27
Enterprise Value to NOPAT (EV/NOPAT)
17.70 47.01 17.99 56.77 16.03 24.74 30.65 20.18 17.12 20.88 26.69
Enterprise Value to Operating Cash Flow (EV/OCF)
15.14 12.34 14.46 13.51 13.47 14.87 13.74 12.54 9.69 14.21 15.96
Enterprise Value to Free Cash Flow (EV/FCFF)
11.07 19.22 0.00 534.72 27.57 0.00 20.06 15.91 151.43 20.04 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.26 0.32 0.28 0.22 0.13 0.25 0.13 0.11 0.17 0.13 0.17
Long-Term Debt to Equity
0.26 0.32 0.28 0.22 0.13 0.25 0.13 0.11 0.17 0.13 0.17
Financial Leverage
-0.19 -0.22 -0.15 -0.09 -0.12 -0.07 -0.05 -0.15 -0.17 -0.16 -0.09
Leverage Ratio
1.60 1.65 1.67 1.60 1.51 1.52 1.53 1.45 1.46 1.44 1.43
Compound Leverage Factor
1.62 1.71 1.60 1.52 1.50 1.49 1.46 1.49 1.44 1.47 1.43
Debt to Total Capital
20.56% 24.36% 22.09% 18.16% 11.68% 19.75% 11.42% 9.74% 14.18% 11.36% 14.67%
Short-Term Debt to Total Capital
0.00% 0.00% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
20.56% 24.36% 21.84% 18.16% 11.68% 19.75% 11.42% 9.74% 14.18% 11.36% 14.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
79.44% 75.64% 77.91% 81.84% 88.32% 80.25% 88.58% 90.26% 85.82% 88.64% 85.33%
Debt to EBITDA
1.40 3.54 1.17 1.21 0.62 1.32 0.73 -1.53 0.75 0.66 0.89
Net Debt to EBITDA
-1.11 -2.59 -0.31 -0.59 -0.63 -0.01 -0.50 2.80 -0.66 -0.94 -0.03
Long-Term Debt to EBITDA
1.40 3.54 1.16 1.21 0.62 1.32 0.73 -1.53 0.75 0.66 0.89
Debt to NOPAT
2.63 8.83 2.38 5.52 1.02 2.58 1.59 0.93 1.22 1.12 1.54
Net Debt to NOPAT
-2.09 -6.45 -0.62 -2.70 -1.04 -0.01 -1.08 -1.71 -1.07 -1.59 -0.05
Long-Term Debt to NOPAT
2.63 8.83 2.35 5.52 1.02 2.58 1.59 0.93 1.22 1.12 1.54
Altman Z-Score
4.78 3.99 4.65 4.94 5.67 4.78 5.62 5.33 5.60 6.37 6.46
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.01 2.60 2.20 2.28 2.30 2.45 2.22 2.53 2.89 3.29 2.50
Quick Ratio
2.39 2.24 1.80 1.80 1.74 1.84 1.65 1.96 2.20 2.50 1.76
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
46 25 -41 1.47 28 -39 53 68 7.76 63 -38
Operating Cash Flow to CapEx
416.97% 499.06% 575.35% 330.70% 204.15% 298.23% 516.78% 550.74% 845.58% 602.60% 532.55%
Free Cash Flow to Firm to Interest Expense
19.61 9.56 -11.03 0.44 13.63 -14.72 16.07 32.18 3.54 18.91 -8.96
Operating Cash Flow to Interest Expense
14.34 14.90 12.75 17.36 27.89 24.32 23.47 40.81 55.29 26.66 23.44
Operating Cash Flow Less CapEx to Interest Expense
10.90 11.91 10.53 12.11 14.23 16.17 18.93 33.40 48.75 22.24 19.04
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.86 0.81 0.79 0.80 0.86 0.79 0.67 0.79 0.83 0.74 0.68
Accounts Receivable Turnover
6.76 6.86 6.77 6.35 6.27 5.95 5.33 6.29 6.78 6.49 6.60
Inventory Turnover
9.12 9.72 9.62 8.66 7.63 7.27 6.47 6.88 6.73 5.88 5.75
Fixed Asset Turnover
5.52 5.41 5.22 4.97 5.01 4.59 4.19 5.28 6.04 5.80 5.52
Accounts Payable Turnover
6.06 6.10 6.38 6.33 6.04 6.22 5.77 6.19 6.92 7.44 7.58
Days Sales Outstanding (DSO)
54.01 53.21 53.91 57.47 58.22 61.30 68.42 58.06 53.84 56.20 55.28
Days Inventory Outstanding (DIO)
40.03 37.53 37.93 42.14 47.84 50.24 56.42 53.02 54.20 62.07 63.48
Days Payable Outstanding (DPO)
60.20 59.81 57.22 57.64 60.44 58.72 63.21 58.94 52.74 49.09 48.12
Cash Conversion Cycle (CCC)
33.84 30.93 34.61 41.97 45.62 52.82 61.63 52.14 55.30 69.19 70.63
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
230 215 294 307 327 405 387 372 433 430 528
Invested Capital Turnover
1.69 1.72 1.56 1.41 1.49 1.28 1.07 1.35 1.46 1.28 1.08
Increase / (Decrease) in Invested Capital
-17 -15 79 12 20 78 -18 -14 61 -2.54 97
Enterprise Value (EV)
505 483 682 784 783 957 1,055 1,081 1,175 1,262 1,585
Market Capitalization
564 549 706 822 834 958 1,092 1,172 1,248 1,358 1,588
Book Value per Share
$8.66 $8.63 $9.70 $10.44 $11.42 $12.43 $13.13 $14.39 $15.88 $16.91 $17.63
Tangible Book Value per Share
$6.61 $6.53 $5.85 $6.25 $7.46 $6.56 $7.28 $8.81 $7.71 $8.51 $5.55
Total Capital
365 372 408 420 428 505 478 514 590 594 622
Total Debt
75 91 90 76 50 100 55 50 84 68 91
Total Long-Term Debt
75 91 89 76 50 100 55 50 84 68 91
Net Debt
-60 -66 -24 -37 -51 -0.54 -37 -91 -73 -96 -3.08
Capital Expenditures (CapEx)
8.00 7.85 8.20 18 28 22 15 16 14 15 19
Debt-free, Cash-free Net Working Capital (DFCFNWC)
26 -5.59 4.78 18 34 40 37 34 56 58 52
Debt-free Net Working Capital (DFNWC)
160 151 119 131 135 141 128 175 213 222 147
Net Working Capital (NWC)
160 151 118 131 135 141 128 175 213 222 147
Net Nonoperating Expense (NNE)
2.01 3.32 3.56 -0.63 2.35 2.55 -0.27 95 9.05 -0.08 1.27
Net Nonoperating Obligations (NNO)
-60 -66 -24 -37 -51 -0.54 -37 -91 -73 -96 -3.08
Total Depreciation and Amortization (D&A)
15 14 17 21 23 25 27 27 30 29 31
Debt-free, Cash-free Net Working Capital to Revenue
6.41% -1.46% 1.20% 4.17% 7.32% 8.59% 8.61% 6.54% 9.60% 10.62% 10.16%
Debt-free Net Working Capital to Revenue
39.71% 39.58% 29.89% 31.02% 28.77% 29.96% 30.25% 34.12% 36.33% 40.39% 28.45%
Net Working Capital to Revenue
39.71% 39.58% 29.64% 31.02% 28.77% 29.96% 30.25% 34.12% 36.33% 40.39% 28.45%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.79 $0.21 $1.05 $0.44 $1.41 $1.11 $1.07 ($1.30) $1.86 $1.93 $1.91
Adjusted Weighted Average Basic Shares Outstanding
33.62M 32.96M 32.73M 32.89M 33.02M 32.70M 32.32M 32.33M 31.97M 31.36M 30.41M
Adjusted Diluted Earnings per Share
$0.78 $0.21 $1.03 $0.43 $1.39 $1.09 $1.06 ($1.30) $1.85 $1.92 $1.89
Adjusted Weighted Average Diluted Shares Outstanding
34.13M 33.48M 33.25M 33.42M 33.57M 33.11M 32.58M 32.33M 32.24M 31.58M 30.72M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
33.44M 32.58M 32.76M 32.94M 32.73M 64.87M 32.35M 32.15M 31.67M 30.79M 30.04M
Normalized Net Operating Profit after Tax (NOPAT)
31 26 33 30 53 44 36 55 70 66 63
Normalized NOPAT Margin
7.73% 6.69% 8.29% 7.17% 11.25% 9.38% 8.45% 10.67% 11.93% 12.02% 12.26%
Pre Tax Income Margin
9.74% 3.21% 14.43% 9.52% 12.35% 10.72% 10.72% -11.87% 13.76% 13.65% 13.81%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
16.72 4.50 16.11 12.66 27.99 19.33 14.58 -28.24 37.23 22.17 16.80
NOPAT to Interest Expense
12.26 3.91 10.25 4.13 23.44 14.61 10.52 25.36 31.31 18.15 14.02
EBIT Less CapEx to Interest Expense
13.28 1.51 13.89 7.41 14.33 11.17 10.04 -35.65 30.69 17.75 12.40
NOPAT Less CapEx to Interest Expense
8.83 0.92 8.03 -1.12 9.78 6.46 5.98 17.95 24.77 13.72 9.62
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
20.26% 76.09% 15.22% 36.41% 11.36% 14.49% 14.93% -12.36% 8.61% 8.33% 8.41%
Augmented Payout Ratio
50.43% 336.20% 15.22% 36.41% 31.64% 46.99% 38.23% -33.34% 44.61% 75.94% 81.70%

Quarterly Metrics and Ratios for CTS

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
24.13% 7.36% -1.15% 0.14% -11.43% -12.36% -13.87% -10.35% -1.58% 2.20%
EBITDA Growth
130.71% 31.83% -10.96% -4.92% 2.35% -15.94% -30.28% 6.08% 18.22% 9.27%
EBIT Growth
119.52% 37.15% -14.45% -8.31% 7.49% -18.53% -41.48% 8.44% 21.29% 7.40%
NOPAT Growth
16.32% 35.83% -12.51% -12.47% -12.19% -9.19% -33.94% -0.55% 31.80% 5.49%
Net Income Growth
118.46% 63.01% -9.36% 2.37% 18.42% 2.54% -39.39% 14.03% 33.73% -11.19%
EPS Growth
118.78% 70.37% -7.94% 5.13% 18.92% 6.52% -37.93% 17.07% 38.64% -10.20%
Operating Cash Flow Growth
183.08% -2.17% -42.00% 45.78% -63.34% 25.97% 63.70% -16.19% 59.91% -19.07%
Free Cash Flow Firm Growth
-247.63% -275.29% -2,190.52% 161.08% 107.45% 136.78% 225.78% -21.35% -3,330.92% -594.52%
Invested Capital Growth
13.02% 16.36% 11.58% -6.41% 2.58% -0.59% -5.43% -4.70% 22.63% 22.61%
Revenue Q/Q Growth
4.78% -6.34% 2.61% -0.56% -7.32% -7.33% 0.85% 3.51% 1.74% -3.77%
EBITDA Q/Q Growth
4.77% 13.16% 1.65% -21.11% 12.78% -7.05% -15.70% 20.05% 25.67% -14.08%
EBIT Q/Q Growth
1.23% 18.79% 7.63% -29.16% 18.68% -9.96% -22.70% 31.27% 32.75% -20.28%
NOPAT Q/Q Growth
-8.56% 0.74% 15.14% -17.47% -8.26% 4.18% -16.24% 24.24% 21.57% -16.62%
Net Income Q/Q Growth
-6.35% 26.63% 22.78% -29.69% 8.33% 9.66% -27.42% 32.27% 27.03% -27.18%
EPS Q/Q Growth
-5.13% 24.32% 26.09% -29.31% 7.32% 11.36% -26.53% 33.33% 27.08% -27.87%
Operating Cash Flow Q/Q Growth
275.87% -57.84% -56.06% 109.38% -5.49% 44.88% -42.90% 7.20% 80.32% -26.67%
Free Cash Flow Firm Q/Q Growth
54.47% -33.70% 36.25% 257.37% -94.45% 560.41% 118.01% -1.59% -328.04% -1.08%
Invested Capital Q/Q Growth
-10.47% 1.12% 4.13% -0.73% -1.86% -2.00% -0.95% 0.03% 26.29% -2.02%
Profitability Metrics
- - - - - - - - - -
Gross Margin
35.12% 35.85% 35.38% 34.95% 34.49% 33.73% 35.86% 35.63% 37.60% 37.59%
EBITDA Margin
16.74% 20.23% 20.04% 15.90% 19.35% 19.40% 16.22% 18.81% 23.24% 20.75%
Operating Margin
14.91% 15.20% 15.19% 12.70% 13.52% 13.04% 11.56% 13.65% 16.22% 14.91%
EBIT Margin
11.50% 14.59% 15.30% 10.90% 13.96% 13.56% 10.40% 13.18% 17.20% 14.25%
Profit (Net Income) Margin
7.77% 10.50% 12.56% 8.88% 10.38% 12.29% 8.84% 11.30% 14.11% 10.68%
Tax Burden Percent
68.20% 71.93% 80.78% 80.21% 74.56% 86.91% 81.41% 82.77% 83.23% 78.42%
Interest Burden Percent
99.00% 100.07% 101.65% 101.61% 99.76% 104.23% 104.47% 103.54% 98.53% 95.52%
Effective Tax Rate
31.80% 28.07% 19.22% 19.79% 25.44% 13.09% 18.59% 17.23% 16.77% 21.58%
Return on Invested Capital (ROIC)
14.54% 15.94% 16.80% 12.88% 13.20% 14.45% 11.38% 13.32% 14.16% 12.59%
ROIC Less NNEP Spread (ROIC-NNEP)
19.71% 16.69% 16.18% 17.50% 12.64% 13.04% 12.28% 13.31% 12.02% 15.20%
Return on Net Nonoperating Assets (RNNOA)
-2.93% -2.83% -2.27% -1.42% -1.82% -2.14% -1.88% -2.17% -0.86% -1.43%
Return on Equity (ROE)
11.61% 13.11% 14.53% 11.46% 11.38% 12.30% 9.50% 11.15% 13.30% 11.16%
Cash Return on Invested Capital (CROIC)
3.80% 1.93% 4.53% 20.46% 11.70% 14.59% 17.98% 17.23% -8.35% -7.92%
Operating Return on Assets (OROA)
9.57% 12.12% 12.51% 8.59% 10.65% 10.02% 7.45% 9.17% 11.44% 9.75%
Return on Assets (ROA)
6.46% 8.72% 10.27% 7.00% 7.92% 9.08% 6.34% 7.86% 9.38% 7.31%
Return on Common Equity (ROCE)
11.61% 13.11% 14.53% 11.46% 11.38% 12.30% 9.50% 11.15% 13.30% 11.16%
Return on Equity Simple (ROE_SIMPLE)
10.97% 0.00% 11.22% 11.12% 11.51% 0.00% 10.23% 10.54% 11.27% 0.00%
Net Operating Profit after Tax (NOPAT)
15 16 18 15 14 14 12 15 18 15
NOPAT Margin
10.17% 10.93% 12.27% 10.18% 10.08% 11.33% 9.41% 11.30% 13.50% 11.70%
Net Nonoperating Expense Percent (NNEP)
-5.17% -0.75% 0.62% -4.63% 0.56% 1.41% -0.90% 0.00% 2.14% -2.61%
Return On Investment Capital (ROIC_SIMPLE)
- 2.64% - - - 2.38% - - - 2.40%
Cost of Revenue to Revenue
64.88% 64.15% 64.62% 65.05% 65.51% 66.27% 64.14% 64.37% 62.40% 62.41%
SG&A Expenses to Revenue
15.80% 16.51% 15.05% 16.32% 13.87% 15.62% 17.70% 16.39% 17.00% 17.41%
R&D to Revenue
4.09% 3.80% 4.51% 4.63% 4.70% 4.24% 5.25% 4.68% 3.80% 4.45%
Operating Expenses to Revenue
20.21% 20.65% 20.19% 22.25% 20.97% 20.70% 24.30% 21.98% 21.38% 22.67%
Earnings before Interest and Taxes (EBIT)
17 21 22 16 19 17 13 17 23 18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
25 29 29 23 26 24 20 24 31 26
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.69 2.47 3.03 2.57 2.50 2.58 2.79 2.96 2.77 2.99
Price to Tangible Book Value (P/TBV)
5.37 5.08 6.27 5.22 4.93 5.12 5.50 5.74 9.47 9.50
Price to Revenue (P/Rev)
2.28 2.13 2.66 2.29 2.30 2.47 2.75 3.00 2.86 3.08
Price to Earnings (P/E)
24.51 20.95 27.03 23.11 21.68 22.44 27.33 28.08 24.55 27.33
Dividend Yield
0.39% 0.41% 0.33% 0.38% 0.38% 0.37% 0.34% 0.32% 0.33% 0.30%
Earnings Yield
4.08% 4.77% 3.70% 4.33% 4.61% 4.46% 3.66% 3.56% 4.07% 3.66%
Enterprise Value to Invested Capital (EV/IC)
2.93 2.71 3.32 2.83 2.78 2.93 3.19 3.40 2.74 3.00
Enterprise Value to Revenue (EV/Rev)
2.18 2.00 2.56 2.16 2.15 2.29 2.57 2.82 2.88 3.07
Enterprise Value to EBITDA (EV/EBITDA)
12.03 10.55 13.88 11.88 11.39 12.30 14.53 15.26 14.79 15.52
Enterprise Value to EBIT (EV/EBIT)
16.53 14.40 19.22 16.57 15.71 17.09 21.08 22.02 21.12 22.27
Enterprise Value to NOPAT (EV/NOPAT)
19.43 17.12 22.61 19.77 19.76 20.88 25.05 26.75 25.20 26.69
Enterprise Value to Operating Cash Flow (EV/OCF)
10.32 9.69 13.23 10.51 14.85 14.21 14.19 15.75 14.01 15.96
Enterprise Value to Free Cash Flow (EV/FCFF)
81.93 151.43 77.23 13.37 24.06 20.04 17.27 19.27 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.17 0.17 0.16 0.15 0.15 0.13 0.13 0.12 0.19 0.17
Long-Term Debt to Equity
0.17 0.17 0.16 0.15 0.15 0.13 0.13 0.12 0.19 0.17
Financial Leverage
-0.15 -0.17 -0.14 -0.08 -0.14 -0.16 -0.15 -0.16 -0.07 -0.09
Leverage Ratio
1.46 1.46 1.44 1.47 1.47 1.44 1.43 1.42 1.47 1.43
Compound Leverage Factor
1.45 1.46 1.46 1.50 1.47 1.50 1.49 1.47 1.44 1.36
Debt to Total Capital
14.84% 14.18% 13.50% 12.87% 12.79% 11.36% 11.46% 11.06% 16.21% 14.67%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
14.84% 14.18% 13.50% 12.87% 12.79% 11.36% 11.46% 11.06% 16.21% 14.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
85.16% 85.82% 86.50% 87.13% 87.21% 88.64% 88.54% 88.94% 83.79% 85.33%
Debt to EBITDA
0.82 0.75 0.74 0.72 0.72 0.66 0.72 0.68 1.03 0.89
Net Debt to EBITDA
-0.60 -0.66 -0.59 -0.69 -0.78 -0.94 -1.01 -1.01 0.08 -0.03
Long-Term Debt to EBITDA
0.82 0.75 0.74 0.72 0.72 0.66 0.72 0.68 1.03 0.89
Debt to NOPAT
1.32 1.22 1.21 1.20 1.24 1.12 1.24 1.20 1.75 1.54
Net Debt to NOPAT
-0.97 -1.07 -0.96 -1.15 -1.35 -1.59 -1.75 -1.77 0.13 -0.05
Long-Term Debt to NOPAT
1.32 1.22 1.21 1.20 1.24 1.12 1.24 1.20 1.75 1.54
Altman Z-Score
5.46 5.33 6.30 5.69 5.68 6.12 6.45 6.94 5.53 6.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.68 2.89 3.05 3.08 3.23 3.29 3.32 3.41 2.46 2.50
Quick Ratio
2.01 2.20 2.28 2.32 2.41 2.50 2.53 2.67 1.75 1.76
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-34 -45 -29 45 2.52 17 36 36 -82 -82
Operating Cash Flow to CapEx
2,661.39% 501.83% 246.39% 593.39% 805.20% 915.73% 453.80% 423.31% 914.36% 425.41%
Free Cash Flow to Firm to Interest Expense
-99.10 -64.55 -41.62 55.58 2.53 20.28 45.36 42.92 -62.38 -63.64
Operating Cash Flow to Interest Expense
176.57 36.27 16.12 28.63 22.20 39.01 22.86 23.56 27.08 20.04
Operating Cash Flow Less CapEx to Interest Expense
169.94 29.04 9.58 23.81 19.44 34.75 17.82 18.00 24.12 15.33
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.83 0.83 0.82 0.79 0.76 0.74 0.72 0.70 0.66 0.68
Accounts Receivable Turnover
6.59 6.78 6.07 5.96 6.09 6.49 5.94 5.63 5.83 6.60
Inventory Turnover
6.45 6.73 6.51 5.98 5.72 5.88 5.71 5.87 5.38 5.75
Fixed Asset Turnover
6.13 6.04 6.05 6.02 6.02 5.80 5.64 5.52 5.51 5.52
Accounts Payable Turnover
6.43 6.92 6.65 6.66 6.37 7.44 6.99 7.13 6.96 7.58
Days Sales Outstanding (DSO)
55.41 53.84 60.13 61.25 59.94 56.20 61.40 64.79 62.58 55.28
Days Inventory Outstanding (DIO)
56.56 54.20 56.07 61.08 63.86 62.07 63.98 62.18 67.90 63.48
Days Payable Outstanding (DPO)
56.72 52.74 54.86 54.84 57.26 49.09 52.25 51.16 52.47 48.12
Cash Conversion Cycle (CCC)
55.24 55.30 61.35 67.49 66.54 69.19 73.13 75.81 78.00 70.63
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
428 433 451 448 439 430 426 427 539 528
Invested Capital Turnover
1.43 1.46 1.37 1.26 1.31 1.28 1.21 1.18 1.05 1.08
Increase / (Decrease) in Invested Capital
49 61 47 -31 11 -2.54 -25 -21 99 97
Enterprise Value (EV)
1,256 1,175 1,496 1,266 1,221 1,262 1,362 1,451 1,477 1,585
Market Capitalization
1,319 1,248 1,559 1,340 1,304 1,358 1,457 1,548 1,469 1,588
Book Value per Share
$15.40 $15.88 $16.24 $16.53 $16.67 $16.91 $16.96 $17.10 $17.48 $17.63
Tangible Book Value per Share
$7.70 $7.71 $7.86 $8.14 $8.44 $8.51 $8.62 $8.83 $5.11 $5.55
Total Capital
576 590 594 598 599 594 589 588 634 622
Total Debt
85 84 80 77 77 68 68 65 103 91
Total Long-Term Debt
85 84 80 77 77 68 68 65 103 91
Net Debt
-62 -73 -63 -74 -83 -96 -95 -96 7.83 -3.08
Capital Expenditures (CapEx)
2.27 5.07 4.54 3.95 2.75 3.50 4.04 4.64 3.87 6.10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
57 56 73 72 71 58 60 61 57 52
Debt-free Net Working Capital (DFNWC)
204 213 217 223 231 222 222 222 152 147
Net Working Capital (NWC)
204 213 217 223 231 222 222 222 152 147
Net Nonoperating Expense (NNE)
3.65 0.62 -0.43 1.89 -0.41 -1.19 0.71 -0.00 -0.81 1.30
Net Nonoperating Obligations (NNO)
-62 -73 -63 -74 -83 -96 -95 -96 7.83 -3.08
Total Depreciation and Amortization (D&A)
7.96 8.03 6.92 7.26 7.25 7.29 7.33 7.33 7.99 8.28
Debt-free, Cash-free Net Working Capital to Revenue
9.80% 9.60% 12.53% 12.27% 12.46% 10.62% 11.29% 11.87% 11.09% 10.16%
Debt-free Net Working Capital to Revenue
35.43% 36.33% 37.06% 38.04% 40.65% 40.39% 41.92% 43.17% 29.58% 28.45%
Net Working Capital to Revenue
35.43% 36.33% 37.06% 38.04% 40.65% 40.39% 41.92% 43.17% 29.58% 28.45%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.37 $0.47 $0.58 $0.41 $0.45 $0.49 $0.36 $0.48 $0.62 $0.45
Adjusted Weighted Average Basic Shares Outstanding
31.87M 31.97M 31.63M 31.49M 31.30M 31.36M 30.74M 30.51M 30.30M 30.41M
Adjusted Diluted Earnings per Share
$0.37 $0.46 $0.58 $0.41 $0.44 $0.49 $0.36 $0.48 $0.61 $0.44
Adjusted Weighted Average Diluted Shares Outstanding
32.09M 32.24M 31.89M 31.69M 31.51M 31.58M 30.99M 30.73M 30.54M 30.72M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
31.88M 31.67M 31.54M 31.36M 31.16M 30.79M 30.57M 30.37M 30.12M 30.04M
Normalized Net Operating Profit after Tax (NOPAT)
16 16 19 16 16 15 13 16 19 16
Normalized NOPAT Margin
10.39% 11.18% 12.77% 11.23% 11.87% 12.06% 10.51% 12.05% 13.98% 12.34%
Pre Tax Income Margin
11.39% 14.60% 15.55% 11.08% 13.93% 14.14% 10.86% 13.65% 16.95% 13.61%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
51.09 29.57 32.19 19.35 18.84 20.57 16.32 20.60 17.43 14.02
NOPAT to Interest Expense
45.16 22.16 25.81 18.07 13.60 17.19 14.77 17.65 13.68 11.51
EBIT Less CapEx to Interest Expense
44.46 22.34 25.65 14.52 16.08 16.31 11.28 15.03 14.47 9.31
NOPAT Less CapEx to Interest Expense
38.52 14.94 19.27 13.25 10.85 12.93 9.74 12.08 10.71 6.80
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
9.57% 8.61% 8.87% 8.78% 8.43% 8.33% 9.38% 9.01% 8.23% 8.41%
Augmented Payout Ratio
41.71% 44.61% 54.51% 55.94% 64.77% 75.94% 92.08% 92.93% 91.51% 81.70%

Frequently Asked Questions About CTS's Financials

When does CTS's financial year end?

According to the most recent income statement we have on file, CTS's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CTS's net income changed over the last 10 years?

CTS's net income appears to be on an upward trend, with a most recent value of $58.11 million in 2024, rising from $26.52 million in 2014. The previous period was $60.53 million in 2023.

What is CTS's operating income?
CTS's total operating income in 2024 was $72.78 million, based on the following breakdown:
  • Total Gross Profit: $189.15 million
  • Total Operating Expenses: $116.37 million
How has CTS revenue changed over the last 10 years?

Over the last 10 years, CTS's total revenue changed from $404.02 million in 2014 to $515.77 million in 2024, a change of 27.7%.

How much debt does CTS have?

CTS's total liabilities were at $235.26 million at the end of 2024, a 9.8% increase from 2023, and a 40.8% increase since 2014.

How much cash does CTS have?

In the past 10 years, CTS's cash and equivalents has ranged from $91.77 million in 2020 to $163.88 million in 2023, and is currently $94.33 million as of their latest financial filing in 2024.

How has CTS's book value per share changed over the last 10 years?

Over the last 10 years, CTS's book value per share changed from 8.66 in 2014 to 17.63 in 2024, a change of 103.6%.

Remove Ads


This page (NYSE:CTS) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners